Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | PRKCA | P17252 | 3/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6331819 | 0.83 | POLB (0.30) | POLBMAPTRAB9A | |
| SCHEMBL6330248 | 0.83 | MAPT (0.53) | POLBMAPTRAB9APRKCA | |
| SCHEMBL6325238 | 0.82 | — | — | |
| SCHEMBL6400697 | 0.77 | KDM4E (0.34) | RAB9A | |
| SCHEMBL6400703 | 0.77 | KDM4E (0.34) | RAB9A | |
| SCHEMBL6325668 | 0.77 | MEN1 (0.41) | MAPTRAB9A | |
| SCHEMBL6327394 | 0.76 | KDM4E (0.33) | RAB9A | |
| SCHEMBL6327398 | 0.76 | KDM4E (0.33) | RAB9A | |
| SCHEMBL6333072 | 0.75 | MEN1 (0.40) | MAPTRAB9A | |
| SCHEMBL6323940 | 0.75 | KDM4E (0.44) | RAB9APRKCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050009928-A1 | Cyclopentanone derivative | ZEON CORPORATION (JP) | 2005-01-13 | — | — | US | disclosed |
| EP-1420005-A1 | CYCLOPENTANONE DERIVATIVE | Zeon Corporation (JP) | 2004-05-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050009928-A1 | Cyclopentanone derivative | PTGIS, CYP51A1, TRPA1 | POLB 1273/4885MAPT 3445/4885RAB9A 4009/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.